Skip to main content

Table 1 Characteristics of the eligible studies

From: Sero-prevalence of human immunodeficiency virus–hepatitis B virus (HIV–HBV) co-infection among pregnant women attending antenatal care (ANC) in sub-Saharan Africa (SSA) and the associated risk factors: a systematic review and meta-analysis

First author, year Country Study design Sampling technique Sample HBV/HIV co-infection Diagnostic Method QS
Andersson et al. [14] South Africa Cross-section Purposive 3089 53 ELISA 8
Bafa et al. [27] Ethiopia Cross-section Random 222 4 RDT 9
Chasela et al. [32] Malawi Cross-section Entire 2048 103 ELISA 9
Desalegn et al. [28] Ethiopia Cross-section Entire 202 1 EIA 6
Dionne-Odom et al. [60] Cameroon Cross-section Consecutive 7069 205 RDT 9
Ezechi et al. [46] Nigeria Cross-section Purposive 2391 101 ELISA 9
Ilboudo et al. [39] Burkina Faso Cross-section Purposive 115 14 RDT 6
Mbaawuaga et al. [47] Nigeria Cross-section Purposive 507 5 RDT 7
Mpody et al. [61] DR Congo Cross-section Entire 1377 65 ELISA 8
Abwonga et al. [55] Cameroon Cross-section Entire 301 5 RDT 7
Adesina et al. [48] Nigeria Cross-section Entire 721 64 ELISA 7
Amsalu et al. [29] Ethiopia Cross-section Purposive 475 10 RDT 8
Andreotti et al. [33] Malawi Cross-section Entire 309 28 RDT 7
Bassey et al. [49] Nigeria Cross-section Purposive 500 36 ELISA 8
Bayo et al. [37] Uganda Cross-section Random 402 4 ELISA 7
Dabsu et al. [30] Ethiopia Cross-section Convenient 421 1 RDT 8
Fomulu et al. [56] Cameroon Cross-section Consecutive 959 7 ELISA 8
Frempong et al. [41] Ghana Cross-section Consecutive 248 22 EIA 8
Helegbe et al. [42] Ghana Cross-section Purposive 3127 1 VCIA 9
Ikeako et al. [50] Nigeria Retrospective Entire 1239 3 ELISA 9
Kfutwah et al. [57] Cameroon Cross-section Entire 650 28 RDT 8
Lar et al. [18] Nigeria Cross-section Entire 135 16 ELISA 8
MacLean et al. [45] Mali Cross-section Entire 3659 14 ELISA 8
Manyahi et al. [36] Tanzania Cross-section Consecutive 249 7 ELISA 8
Mutagoma et al. [34] Rwanda Cross-section Entire 13,121 20 ELISA 9
Noubiap et al. [58] Cameroon Cross-section Consecutive 325 5 RDT 7
Ntiamoah et al. [43] Ghana Cross-section Purposive 124 11 RDT 6
Ojiegbe et al. [51] Nigeria Cross-section Purposive 300 3 ELISA 6
Pirillo et al. [35] Rwanda Cross-section Entire 82 2 RDT 7
Pirillo et al. [35] Uganda Cross-section Entire 164 8 ELISA 7
Rouet et al. [44] Ivory cost Retrospective Entire 449 45 ELISA 8
Seremba et al. [38] Uganda Cross-section Purposive 612 9 AAS 7
Simpore et al. [40] Burkina Faso Cross-section Entire 336 24 AAS 7
Tanjong Re et al. [59] Cameroon Cross-section Purposive 406 6 AAS 8
Thumbiran et al. [54] South Africa Cross-section Entire 570 18 ELISA 6
Usanga et al. [52] Nigeria Cross-section Purposive 562 5 ELISA 8
Ya’aba et al. [53] Nigeria Cross-section Purposive 330 90 ELISA 7
Zenebe et al. [31] Ethiopia Cross-section Random 318 4 RDT 9
  1. VCIA vitros chemi luminescent immunoassay, AAS abbott ARCHITECT system, ELISA enzyme linked immuno assay, EIA enzyme immuno assay, RDT rapid diagnostic test, QS quality score
Back to article page

Virology Journal

ISSN: 1743-422X